By Sara Stefanini ( October 29, 2007, 12:00 AM EDT) -- As the U.S. Patent and Trademark Office prepares to implement its set of hotly contested new rules on Thursday, opponents are eagerly awaiting a hearing on GlaxoSmithKline's motion for an injunction, hoping that it will succeed in stopping the change for now at least....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.